Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
Kate Haviland
Greater Boston,United States
Find Kate Haviland's Email
Find Kate Haviland's PhoneWho Is Kate Haviland?
Kate Haviland is a distinguished leader in the biopharmaceutical industry, currently serving as the President and Chief Executive Officer of Blueprint Medicines. With nearly two decades of experience, she has a proven track record in corporate strategy, business development, and commercial execution. Before her appointment as CEO in April 2022, she held key leadership roles within Blueprint Medicines, including Chief Operating Officer and Chief Business Officer, where she was instrumental in transforming the company into a fully integrated, commercial-stage organization. Her career began at Genzyme and includes significant tenures at PTC Therapeutics and Ipsen, where she led strategic transactions and corporate development initiatives. Kate is recognized for her strategic vision in advancing precision therapies from research to global commercialization.
How Did Kate Haviland's Career Path Shape Their Journey?
Kate Haviland's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
What Are Kate Haviland's Key Achievements?
Led Blueprint Medicines' Transition to a Commercial Company
As COO and CBO, she was a key architect behind the successful global commercial launches of the company's first two precision therapies, AYVAKIT® (avapritinib) and GAVRETO® (pralsetinib), establishing Blueprint Medicines as a leader in the market.
Architect of a Landmark Strategic Collaboration
Spearheaded the negotiation and execution of a major global collaboration with Roche for the co-development and commercialization of GAVRETO®, a deal valued at up to $1.7 billion, significantly amplifying the therapy's potential market access and impact.
Ascension to President and CEO
Her appointment to President and CEO reflects the Board of Directors' confidence in her leadership and strategic capabilities to guide Blueprint Medicines through its next phase of growth, innovation, and global expansion.
Board and Advisory Role Influence
Serves on the Board of Directors for Fulcrum Therapeutics and is a member of the Board of Directors of BIO (Biotechnology Innovation Organization), contributing her expertise to shape the broader biotechnology landscape.
What's Kate Haviland's Educational Background?
Degree Program
Harvard Business School - Year 2003
BA, Biochemistry/Molecular Biology and Economics
Wesleyan University - Year 1994
Buying Intent Signals for Kate Haviland
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Company Overview
Blueprint MedicinesBlueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and hematologic disorders. Applying a proven scientific platform, the company is systematically identifying disease drivers, crafting highly selective therapies, and tailoring therapeutic approaches to patient populations based on their genetic makeup. Their portfolio includes approved medicines like AYVAKIT® (avapritinib) and a robust pipeline of investigational therapies.
Highperformr's free tools for company research
Find contact info
Get verified emails, phone numbers, and LinkedIn profile details
Find similar contacts
Discover contacts with similar roles, seniority, or companies
Perform deep contact research
Uncover insights like skills, work history, social links, and more
Discover, research and enrich contacts with Highperformr — Smarter, Faster
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
- Track signals like job change, promotion, and LinkedIn activity
- Enrich contacts with verified email, phone, and social data instantly
- Automate enrichment and updates with powerful workflows
- Sync enriched contact info directly into your CRM and tools
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.